2020
DOI: 10.5114/aoms.2020.93695
|View full text |Cite
|
Sign up to set email alerts
|

Immunohistochemical evaluation of osteopontin expression in triple-negative breast cancer

Abstract: IntroductionTriple-negative breast cancer (TNBC) is associated with lack of expression of estrogen and progesterone receptors and HER2 and is the subgroup of breast cancers with the worst prognosis. Osteopontin is a phosphorylated glycoprotein whose overexpression may occur in pathological states such as cancers. The main purpose of our study was to evaluate the immunohistochemical expression of osteopontin in connection with the analysis of recognized clinical and pathological prognostic factors in primary si… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 40 publications
(61 reference statements)
0
1
0
Order By: Relevance
“…An IRS of ≤ 3 was defined as negative and > 3 was scored as positive. Two experts evaluated all specimens in a blinded manner [32].…”
Section: Immunohistochemistry (Ihc)mentioning
confidence: 99%
“…An IRS of ≤ 3 was defined as negative and > 3 was scored as positive. Two experts evaluated all specimens in a blinded manner [32].…”
Section: Immunohistochemistry (Ihc)mentioning
confidence: 99%